Results 201 to 210 of about 265,886 (307)

Recurrent laryngeal nerve lymph nodes status prediction after neoadjuvant therapy for thoracic esophageal squamous cell carcinoma. [PDF]

Insights Imaging
Wu F, Luo C, Zhou S, Peng Z, Ruan G, Yang X, Li S, Huang W, Liu L, Zhou J, Liang B, Li H.   +11 more
europepmc   +1 more source

Optimizing Lymph Node Staging in Gallbladder Cancer: A Cutoff of 11 Nodes for Accurate Staging and Improved Survival

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background Gallbladder cancer (GBC) is an aggressive malignancy in which lymph node (LN) status is a key prognostic factor. Adequate LN retrieval is essential for accurate nodal staging. This study aimed to identify an LN threshold that reduces false node‐negative (false N0) rates and to evaluate its association with overall survival (OS) as ...
So Jeong Yoon, Hyun Jeong Jeon, Boram Park, Hyeong Seok Kim, Hochang Chae, Sang Hyun Shin, In Woong Han, Jin Seok Heo, Okjoo Lee, Hongbeom Kim   +9 more
wiley   +1 more source

Plasma serine and glycine in relation to clinical outcomes following neoadjuvant radiotherapy for rectal cancer. [PDF]

Clin Transl Radiat Oncol
Zwart NRK, Ueland PM, McCann A, McKay JA, Rütten H, Bogers JA, de Wilt JHW, Kampman E, Kok DE.   +8 more
europepmc   +1 more source

Postoperative Weight Gain, Due to Fluid Retention After Ovarian Cancer Surgery—How Much Is too Much?

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Postoperative complications after cytoreductive surgery in ovarian cancer patients are associated with impaired survival. Here, we investigated the association between postoperative weight gain due to fluid retention and the development of complications and anastomotic leakage (AL).
Eva K. Egger, Melisa Delen, Hanno Matthaei, Laura Tascon Padron, Carolin Schröder, Milka Marinova, Dominique Koensgen, Alexander Mustea   +7 more
wiley   +1 more source

The Tumour Immune Microenvironment as a Predictor of the Response to Neoadjuvant Therapy in Rectal Cancer. [PDF]

Cancers (Basel)
Wadud S, Cheadle EJ, Sutton PA.
europepmc   +1 more source

The Negative Impact of a Non‐Therapeutic Laparotomy in Patients With Inoperable Colorectal Peritoneal Metastases

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background The peritoneum is the third most prevalent location for metastases of colorectal cancer. In patients with resectable disease, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is the preferred treatment in the Netherlands, achieving median overall survival (OS) of 36–42 months. However, during
Teun van den Heuvel, Lars van Kesteren, Simon Nienhuijs, Pim Burger, Tineke Buffart, Jurriaan Tuynman, Ignace De Hingh   +6 more
wiley   +1 more source

Systematic Review and Meta-Analysis of Current and Novel Approaches in the Management of Borderline Resectable and Locally Advanced Pancreatic Cancer. [PDF]

Cancers (Basel)
Le K, Le KDR, Hong W, Gibbs P, Yoshino O, Lee B.   +5 more
europepmc   +1 more source

Inflammatory Markers may Determine Postoperative Complications in Cases of Peritoneal Carcinomatosis of Ovarian Origin Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives This study aimed to evaluate the ability of perioperative inflammatory markers to discriminate postoperative complications within 6 months in patients with ovarian cancer–related peritoneal metastasis undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Donmez Mustafa, Bisgin Tayfun, Manoglu Berke, Sokmen Selman, Sensoy Basoglu Ecem, Boztas Nilay, Ozgul Ozkardesler Sevda   +6 more
wiley   +1 more source

Immune checkpoint inhibitors in resectable non-small cell lung cancer: recent successes and ongoing challenges. [PDF]

Front Oncol
Abodunrin FO, Cameron RB, Haque W, Bestvina CM, Garassino MC.   +4 more
europepmc   +1 more source